Financials

	2024	2025
Net sales	492K 423K 397K 363K 678K 46.51M 684K 4.7M 1.83M 23.77M 1.85M 1.81M 76.55M	89K 76.58K 71.86K 65.75K 123K 8.41M 124K 850K 331K 4.3M 334K 327K 13.85M
Net income	-1.04M -895K -840K -768K -1.43M -98.31M -1.45M -9.93M -3.87M -50.24M -3.91M -3.82M -162M	-3.98M -3.42M -3.21M -2.94M -5.48M -376M -5.53M -37.98M -14.79M -192M -14.93M -14.61M -619M
Net Debt	6.22M 5.35M 5.02M 4.59M 8.57M 588M 8.64M 59.38M 23.13M 300M 23.35M 22.84M 967M	911K 784K 736K 673K 1.26M 86.12M 1.27M 8.7M 3.39M 44.01M 3.42M 3.35M 142M

* Estimated data More financial data

Company Profile

DXI Capital Corp. is a Canada-based company. The Company has no active operations. It does not generate revenue from its operations. The Companyâ€™s wholly owned subsidiary is 0855524 B.C. Ltd.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
03/09/26	CA$0.2100	+5.00%	500
02/09/26	CA$0.2000	+5.26%	1,500
31/08/26	CA$0.1900	-9.52%	12,000
28/08/26	CA$0.2100	-12.50%	18,043
26/08/26	CA$0.2400	+4.35%	24,000

Delayed Quote Toronto S.E.

More quotes

Market Closed - Toronto S.E. 23:19:11 03/09/2026 +04			5-day change	1st Jan Change
0.2100 ^CAD	+5.00%		-12.50%	-30.00%

09-02	Vvt Med Inc. and Dermworks Enter Distribution and Evaluation Agreement for Sclerosafe in Portugal	CI
08-31	VVT Med Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	11.06M 9.51M 8.93M 8.17M 15.24M 1.05B 15.37M 106M 41.13M 534M 41.52M 40.61M 1.72B	P/E 2024 *	-	P/E 2025	-2.71x
Enterprise Value	11.97M 10.3M 9.66M 8.84M 16.5M 1.13B 16.63M 114M 44.52M 578M 44.94M 43.96M 1.86B	EV / Sales 2024 *	-	EV / Sales 2025	175x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Toronto S.E.	VVTM	Delayed
OTC Markets	VVTMF	Delayed

09-02	Vvt Med Inc. and Dermworks Enter Distribution and Evaluation Agreement for Sclerosafe in Portugal	CI
08-31	VVT Med Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-01	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
07-01	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
06-30	VVT Med Inc. Auditor Raises 'Going Concern' Doubt	CI
06-26	VVT Med Signs Exclusive Distribution Deal in Greece Worth About C$1.14 Million	MT
06-26	VVT Med Inc. Enters Exclusive Distribution Agreement With General Chemical Products S.A. For ScleroSafe Platform In Greece	CI
06-11	VVT Med Enters Dominican Republic Market	MT
06-11	VVT Med Inc. Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	CI
05-26	VVT Med Announces First Patients Treated with VVT?s ScleroSafe System in Italy	CI
04-30	VVT Med Inc Announces Positive Clinical Data For ScleroSafe Catheter-Directed Sclerotherapy System	CI
04-27	VVT Med Signs "Largest" European Distribution Agreement to Date	MT
04-27	VVT Med Inc. Signs Exclusive Distribution Agreement With Uber Ros S.p.A. For ScleroSafe System In Italy, Vatican City And Republic Of San Marino	CI

VVT Med Inc. Stock

Stocks

VVTM

CA91841T1084

Medical Equipment, Supplies & Distribution

Valuation : VVT Med Inc.

Chart: VVT Med Inc.

Latest news : VVT Med Inc.

Press Releases : VVT Med Inc.

News in other languages : VVT Med Inc.

Quotes and Performance

Price Extremes

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

09-02	VVT Med Advances Portugal Market Entry as Dermworks Begins ScleroSafe® Market Evaluation and Announces Corporate Updates	AQ
08-22	VVT Med Announces Debt Settlement and Equity Incentive Grants to Strengthen Capital Structure	AQ
06-26	VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece	AQ
06-13	VVT Med Provides Update on Management Cease Trade Order	AQ
06-11	VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	GL

11-26	VVT Medical Inc. (VVTM) ouvre les marchés
23/11/23	Sopra Steria Group: Willy il Coyote cerca di tenere il passo con Bip Bip
23/11/23	Sopra Steria Group: Coyote intenta seguir el ritmo de Bip Bip
23/11/23	Sopra Steria Group : le Coyote tente de suivre Bip Bip

1 day	+5.00%
1 week	-12.50%
Current month	+10.53%
1 month	-4.55%
3 months	+10.53%
6 months	-20.75%
Current year	-30.00%

1 week	0.19	0.21
1 month	0.19	0.27
Current year	0.17	0.45
1 year	0.15	0.45
3 years	0.15	0.56
5 years	0.15	0.56
10 years	0.15	0.56

Date	Insider	Type	Main position	% Market Cap.
28/04/26	Erez Tetro	Other	Chief Executive Officer	0%
27/04/26	Yair Aloni	Other	Chairman	0%
27/04/26	Yair Aloni	Other	Chairman	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VVT MED INC.	+5.00%	-12.50%	-56.70%	-	11.06M
ABBOTT LABORATORIES	-1.52%	-2.51%	-17.70%	+5.78%	188B
MEDTRONIC PLC	+1.00%	+3.48%	+0.92%	+13.36%	119B
CENCORA, INC.	+0.26%	+4.98%	+14.26%	+92.74%	64.35B
HOYA CORPORATION	-1.31%	-1.09%	+22.44%	+46.84%	52.59B
BECTON, DICKINSON AND COMPANY	+0.05%	-0.27%	-1.05%	-32.62%	51.11B
DEXCOM, INC.	+0.02%	+0.47%	+13.67%	-11.96%	33.85B
MEDLINE INC.	+0.80%	+5.60%	-	-	32.1B
WEST PHARMACEUTICAL SERVICES, INC.	+0.03%	-0.97%	+37.67%	-15.93%	24.12B
TERUMO CORPORATION	-1.44%	-4.21%	-7.37%	+11.97%	23.39B
Average	+0.29%	-1.17%	+0.68%	+13.77%	58.89B
Weighted average by Cap.	-0.38%	-0.57%	+0.04%	+16.04%